Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 58.70
-0.25 (-0.42%)
At close: Oct 27, 2026
Sheel Biotech Revenue
In the fiscal year ending March 31, 2026, Sheel Biotech had annual revenue of 1.10B INR with 8.13% growth. Sheel Biotech had revenue of 881.73M in the half year ending March 31, 2026. That makes Sheel Biotech the 36,679th largest company in the world by revenue and 3,113th in India.
Revenue
1.10B
Revenue Growth
+8.13%
P/S Ratio
1.09
Revenue / Employee
7.54M
Employees
146
Market Cap
1.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.10B | 82.70M | 8.13% |
| Mar 31, 2025 | 1.02B | 94.70M | 10.26% |
| Mar 31, 2024 | 922.82M | 121.67M | 15.19% |
| Mar 31, 2023 | 801.16M | 93.80M | 13.26% |
| Mar 31, 2022 | 707.36M | 77.08M | 12.23% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JK Agri Genetics | 1.50B |
| Mangalam Seeds | 1.25B |
| Indo Us Bio-Tech | 1.13B |
| Tierra Agrotech | 1.12B |
| Saptarishi Agro Industries | 937.03M |
| Farm Peace | 908.28M |
| Stanbik Agro | 858.95M |
| Nagarjuna Agri-Tech | 832.38M |